Status:
COMPLETED
Inattention in Childhood Cancer Survivors
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Childhood Cancer
Eligibility:
All Genders
8-16 years
Phase:
NA
Brief Summary
Specific Aim 1: To assess the feasibility and acceptability of a home-based, computerized cognitive training program with survivors of central nervous system-impacting pediatric cancer (e.g. acute lym...
Detailed Description
After obtaining written informed consent (parent) and assent (child), screening procedures will include administration of an abbreviated intellectual test battery, a working memory battery, and a comp...
Eligibility Criteria
Inclusion
- A T-score greater than the 75th percentile on either the Cognitive Problems/Inattention or the DSM-IV Inattention subscales of the Conners' Parent Rating Scale
- One or more standard deviations below the mean on the Attention or Working Memory Indices of the WRAML 2 \[56\] or Attention or Working Memory Indices that are one or more standard deviations below the participant's estimated IQ. These criteria are similar to those used in a trial of methylphenidate with survivors of childhood cancer.
Exclusion
- Estimated IQ ≤ 70
- A motor, visual, or auditory handicap that prevents computer use
- A diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder, depression, autism, or Pervasive Developmental Disorder
- Insufficient fluency in English. Participants who are currently taking stimulant medications (stable dose for at least 30 days) for attentional difficulties, but who meet inclusion criteria listed below will be allowed to participate.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00636337
Start Date
December 1 2007
End Date
November 1 2012
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center Preston Robert Tisch Brain Tumor Center
Durham, North Carolina, United States, 27710